Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sterne

Showing results (551-560 of 669) with videos related to

Pageof 67
Sort By:
Health Technology Assessment (Winchester, England)|March 11, 2017
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysisJonathan Ac Sterne, Pritesh N Bodalia, Peter A Bryden, et al.
Annals of Internal Medicine|September 5, 2012
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trialsJelena Savović, Hayley E Jones, Douglas G Altman, et al.
American Journal of Epidemiology|September 1, 2023
CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLANDElsie M F Horne, William J Hulme, Ruth H Keogh, et al.
The Lancet. Child & Adolescent Health|November 6, 2025
Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health recordsAlexia Sampri, Wen Shi, Thomas Bolton, et al.
International Journal of Antimicrobial Agents|July 13, 2026
Outcomes for persons with triple-class resistant HIV and a history of virologic failureSuzanne M Ingle, Fabrice Bonnet, Linda Wittkop, et al.
Lancet (London, England)|July 20, 2002
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesMatthias Egger, Margaret May, Geneviève Chêne, et al.
International Journal of Epidemiology|November 20, 2016
Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoordGeneviève Chêne, Andrew Phillips, Dominique Costagliola, et al.
Trials|April 10, 2021
Primary Care implementation of Germ Defence, a digital behaviour change intervention to improve household infection control during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trialJeremy Horwood, Melanie Chalder, Ben Ainsworth, et al.
The Lancet. Digital Health|June 11, 2022
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health recordsJohan H Thygesen, Christopher Tomlinson, Sam Hollings, et al.
AIDS (London, England)|August 9, 2013
Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis, Bryan E Shepherd, Cathy A Jenkins, et al.
Pageof 67

Showing results (551-560 of 669) with videos related to

Sort By:
Pageof 67
Health Technology Assessment (Winchester, England)|March 11, 2017
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysisJonathan Ac Sterne, Pritesh N Bodalia, Peter A Bryden, et al.
Annals of Internal Medicine|September 5, 2012
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trialsJelena Savović, Hayley E Jones, Douglas G Altman, et al.
American Journal of Epidemiology|September 1, 2023
CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLANDElsie M F Horne, William J Hulme, Ruth H Keogh, et al.
The Lancet. Child & Adolescent Health|November 6, 2025
Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health recordsAlexia Sampri, Wen Shi, Thomas Bolton, et al.
International Journal of Antimicrobial Agents|July 13, 2026
Outcomes for persons with triple-class resistant HIV and a history of virologic failureSuzanne M Ingle, Fabrice Bonnet, Linda Wittkop, et al.
Lancet (London, England)|July 20, 2002
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesMatthias Egger, Margaret May, Geneviève Chêne, et al.
International Journal of Epidemiology|November 20, 2016
Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoordGeneviève Chêne, Andrew Phillips, Dominique Costagliola, et al.
Trials|April 10, 2021
Primary Care implementation of Germ Defence, a digital behaviour change intervention to improve household infection control during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trialJeremy Horwood, Melanie Chalder, Ben Ainsworth, et al.
The Lancet. Digital Health|June 11, 2022
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health recordsJohan H Thygesen, Christopher Tomlinson, Sam Hollings, et al.
AIDS (London, England)|August 9, 2013
Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis, Bryan E Shepherd, Cathy A Jenkins, et al.
Pageof 67